Showing results (71-80 of 176) with videos related to
Sort By:
Pageof 18
Anticancer Research|November 1, 1995
CD-44 is not involved in the metastatic spread of ovarian cancer in vivoP Speiser, C Wanner, G Breitenecker, et al.Kidney International. Supplement|July 21, 1999
Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie InvestigatorsC Wanner, V Krane, G Ruf, et al.Nephron|January 1, 1988
Chronic ethanol ingestion enhances catabolism and muscle protease activity in acutely uremic ratsM Teschner, R M Schaefer, F Weissinger, et al.Kidney International. Supplement|January 4, 1998
Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a)C Wanner, S Greiber, A Krämer-Guth, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 29, 2000
CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formationJ Galle, C Lehmann-Bodem, U Hübner, et al.Schweizerische Medizinische Wochenschrift|May 23, 1987
[An incidental finding of renal cysts: routine occurrence or a finding deserving clarification?]T F Lüscher, C Wanner, R Otto, et al.Cardiology|January 1, 1985
Curable renal parenchymatous hypertension: current diagnosis and managementT F Lüscher, C Wanner, D Hauri, et al.Nephron|January 1, 1992
Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patientsC Wanner, I Lubrich-Birkner, O Summ, et al.The American Journal of Clinical Nutrition|March 1, 1990
Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patientsC Wanner, B Wäckerle, H Boeckle, et al.Kidney International. Supplement|July 21, 1999
Abnormalities in lipoprotein metabolism in hemodialysis patientsM Königer, T Quaschning, C Wanner, et al.Pageof 18